EX-10.33 63 dex1033.htm MANUFACTURING AND PACKAGING AGREEMENT / CARDINAL HEALTH PTS, LLC MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • May 5th, 2020 • New York
This Manufacturing and Packaging Agreement (“Agreement”) is made this 14th day of April, 2005, by and between Cardinal Health PTS, LLC, having a place of business at 2725 Scherer Drive, St Petersburg, Florida 33716 (“Cardinal Health”) and Reliant Pharmaceuticals, Inc. (“Reliant”), having its principal place of business at 110 Allen Road, Liberty Corner, New Jersey 07938.
AMENDED AND RESTATED MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Quality Agreement does not supercede or amend any provisions in the Supply Agreement between Reliant Pharmaceutical (Reliant) and Cardinal Health (Cardinal) dated April 14, 2005 (as may be amended from time to time, the “Agreement”). In the event of a conflict between the terms of the Agreement and this Quality Agreement, the Agreement shall be controlling.
CONTENTS PAGE ARTICLE 1 Definitions 3 ARTICLE 2 Validation, Manufacture, Packaging & Related Services 6 ARTICLE 3 Materials 7 ARTICLE 4 Minimum Commitment, Purchase Orders & Forecasts 8 ARTICLE 5 Testing; Samples; Release 10 ARTICLE 6 Delivery 11...Manufacturing and Packaging Agreement • March 8th, 2007 • Proton Laboratories Inc • Retail-food stores • California
Exhibit 10.16(a) TOLL MANUFACTURING AND PACKAGING AGREEMENT This Toll Manufacturing and Packaging Agreement (this "Agreement") is made as of this 24th day of August, 1999, by and between Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA...Manufacturing and Packaging Agreement • June 5th, 2002 • Cephalon Inc • Pharmaceutical preparations
SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • July 15th, 2011 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
FIRST AMENDMENT TO SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • February 27th, 2013 • Insys Therapeutics, Inc. • Pharmaceutical preparations
This First Amendment to Softgel Commercial Manufacturing and Packaging Agreement (this “Amendment”), is made as of this 5th day of March 2012 (“Effective Date”), by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
Confidential information redacted and filed separately with the Commission. Omitted portions indicated by [***]. Amendment to Contract Manufacturing and Packaging AgreementManufacturing and Packaging Agreement • October 31st, 2012 • Annie's, Inc. • Food and kindred products
This Amendment (the “Amendment”) dated as of September 25, 2012 to the Contract Manufacturing and Packaging Agreement by and between Annie’s Enterprises, Inc. d/b/a Annie’s Naturals (“Customer”) and Chelten House Products, Inc. (“Manufacturer”) dated May 29, 2009 (the “Agreement”), each a “Party” and together the “Parties.” All capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to them in the Agreement.
SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • May 9th, 2011 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
ContractManufacturing and Packaging Agreement • January 24th, 2005 • LEM America, Inc • Services-amusement & recreation services • New York
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
AMENDED AND RESTATED MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • August 10th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Manufacturing and Packaging Agreement (“Agreement”) is made this day of March, 2007 by and between Cardinal Health PTS, LLC, having a place of business at 2725 Scherer Drive, St Petersburg, Florida 33716 (“Cardinal Health”) and Reliant Pharmaceuticals, Inc. (“Reliant”), having its principal place of business at 110 Allen Road, Liberty Corner, New Jersey 07938. (Cardinal Health and Reliant are each a “Party” and shall collectively be referred to herein as the “Parties.”)
FIRST AMENDMENT TO THE MANUFACTURING AND PACKAGING AGREEMENT BETWEEN CARDINAL HEALTH PTS, LLC AND LIGAND PHARMACEUTICALS INCORPORATEDManufacturing and Packaging Agreement • August 9th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT (the “Amendment”) to the Manufacturing and Packaging Agreement dated 13 February 2004 (the “Agreement”), is made and entered into on this day of May, 2006, between Ligand Pharmaceuticals Incorporated (“Ligand”) and Cardinal Health PTS, LLC (“Cardinal Health”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
